Likewise, in Phase 2 study, 48 participants presented normal PRL levels (mean = 9.81 ± 4.11), and the remaining 12 displayed hyperprolactinemia (mean = 66.04 ± 23.17), of which one patient (8.3%) presented normalized PRL during testing (Table 4). Here, PRL is linked to hyperprolactinemia.